Inventor

Ted M. Dawson

Inventor
Baltimore, MD, US

Overview

18→
Patents
1993–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes9%
C12YEnzymes9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C07DHeterocyclic compounds2%
PatentTitleYear
11,123,405Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions20219,623,039'Treatment and prevention of pathological conditions using iduna related techniques and compositions'20179,309,208'Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors'20169,274,128'Transcriptional repression leading to parkinson\'s disease'20168,921,042'Transcriptional repression leading to Parkinson\'s disease'20148,603,994'Transcriptional repression leading to Parkinson\'s disease'20136,500,843'Inhibitors of rotamase enzyme activity'20026,362,160'Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases'20026,358,975'Method of using selective parp inhibitors to prevent or treat neurotoxicity'20026,080,753'Stimulating nerve growth with immunophilins'20006,022,878'Inhibitors of rotamase enzyme activity'2000RE036397'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity'19995,898,029'Direct influences on nerve growth of agents that interact with immunophilins in combination with neurotrophic factors'19995,846,981'Inhibitors of rotamase enzyme activity'19985,843,960'Inhibitors of rotamase enzyme activity'19985,798,355'Inhibitors of rotamase enzyme activity'19985,587,384'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity'19965,266,594'Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2017Patents assigned to DAWSON TED M (3)· patent assignee history
1993–2021Based in Baltimore, MD, US· patent location history
1996–2021Patents assigned to UNIV JOHNS HOPKINS (7)· patent assignee history
1998–2002Patents assigned to UNIV JOHNS HOPKINS MED (6)· patent assignee history
1998–2002Patents assigned to GUILFORD PHARM INC (5)· patent assignee history
2013–2017Patents assigned to VALTED LLC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV JOHNS HOPKINS71996–2021
UNIV JOHNS HOPKINS MED61998–2002
GUILFORD PHARM INC51998–2002
VALTED LLC42013–2017
DAWSON TED Mself31993–2017
Locations
LocationPatentsSpan
Baltimore, Maryland, US181993–2021